(0.30%) 5 196.46 points
(0.13%) 38 904 points
(0.26%) 16 391 points
(0.24%) $78.67
(0.77%) $2.21
(-0.41%) $2 321.60
(-0.28%) $27.54
(2.40%) $988.10
(0.00%) $0.928
(0.48%) $10.88
(0.23%) $0.798
(-0.07%) $91.28
Live Chart Being Loaded With Signals
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases...
Stats | |
---|---|
Today's Volume | 681 627 |
Average Volume | 795 454 |
Market Cap | 7.58M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $0 ) 2024-06-21 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.00300 (1.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-29 | Staskey Norm | Buy | 47 600 | Common Stock |
2024-02-13 | Whitfill Travis | Buy | 15 000 | Common Stock |
2024-02-13 | Staskey Norm | Buy | 3 300 | Common Stock |
2024-02-13 | Salva Francisco D. | Buy | 333 300 | Common Stock |
2023-09-08 | Staskey Norm | Buy | 10 000 | Stock Options (Right To Buy) |
INSIDER POWER |
---|
44.33 |
Last 69 transactions |
Buy: 15 407 806 | Sell: 6 059 394 |
Volume Correlation
Azitra, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Azitra, Inc. Correlation - Currency/Commodity
Azitra, Inc. Financials
Annual | 2023 |
Revenue: | $686 000 |
Gross Profit: | $686 000 (100.00 %) |
EPS: | $-1.630 |
FY | 2023 |
Revenue: | $686 000 |
Gross Profit: | $686 000 (100.00 %) |
EPS: | $-1.630 |
FY | 2022 |
Revenue: | $284 000 |
Gross Profit: | $284 000 (100.00 %) |
EPS: | $-0.880 |
Financial Reports:
No articles found.
Azitra, Inc.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators